Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

579
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
579
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

6.3K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LacR and TrxB are key virulence factors involved in pneumococcal meningitis as identified by a genome-wide association study.

Communications biology·2026
Same author

Neuroinflammation in Ischemic Stroke: Mechanisms, Systemic Interactions, and Therapeutic Targets.

Translational stroke research·2026
Same author

Group B streptococcal disease in infants 0-3 months in The Netherlands, 1987-2023: a nationwide genomic and epidemiological surveillance study.

The Lancet regional health. Europe·2026
Same author

Brain Abscesses Complicating Bacterial Meningitis-A Nationwide Cohort Study From the Netherlands.

European journal of neurology·2026
Same author

The effects of prophylactic use of paracetamol on body temperature and blood pressure in elderly patients with acute stroke: Data from the PRECIOUS trial.

PloS one·2026
Same author

Association of CRP levels and clinical and radiological outcomes in patients with large-vessel occlusion stroke: A MR CLEAN Registry study.

European stroke journal·2026

Related Experiment Video

Updated: Mar 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Community-acquired bacterial meningitis.

Joost M Costerus1, Matthijs C Brouwer, Merijn W Bijlsma

  • 1Department of Neurology, Centre of Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre, Amsterdam, the Netherlands.

Current Opinion in Infectious Diseases
|November 10, 2016
PubMed
Summary
This summary is machine-generated.

Bacterial meningitis requires prompt treatment, ideally within one hour, to reduce its high disease burden. Advances in diagnostics like PCR are improving identification, while dexamethasone remains a key adjunctive therapy.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.8K

Related Experiment Videos

Last Updated: Mar 12, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

2.8K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Neurology

Background:

  • Bacterial meningitis presents a significant global health challenge with a high disease burden.
  • Despite vaccination efforts, incidence remains concerning, with delayed diagnosis and treatment being critical issues.
  • European Society of Clinical Microbiology and Infectious Diseases guidelines emphasize a door-to-antibiotic time of under 1 hour.

Purpose of the Study:

  • To review recent advancements in managing community-acquired bacterial meningitis.
  • To highlight key findings in the diagnosis and treatment of bacterial meningitis.

Main Methods:

  • Literature review of recent progress in bacterial meningitis management.
  • Analysis of diagnostic tools, including Polymerase Chain Reaction (PCR).
  • Evaluation of therapeutic strategies, including adjunctive therapies like dexamethasone.

Main Results:

  • Polymerase chain reaction (PCR) is a crucial tool for identifying causative organisms in bacterial meningitis.
  • Point-of-care multiplex PCR tests show promise but require further validation.
  • Adjunctive dexamethasone is the only therapy proven effective alongside antibiotics.
  • The efficacy and safety of pressure-based management require further investigation through randomized controlled trials.

Conclusions:

  • Early administration of antibiotics, within 1 hour, is critical for improving outcomes in bacterial meningitis.
  • While vaccines have reduced incidence, prompt management remains paramount.
  • Dexamethasone is a vital adjunctive treatment for bacterial meningitis.